Expert: Blaming Greenpeace for blocking Golden Rice is “sleazy sleight of hand”
By Claire Robinson and Jonathan Matthews,
GMWatch
| 06. 02. 2024
With the recent Philippines court decision blocking the further planting of GM Golden Rice in the country, pro-GMO advocates have renewed their attacks on Greenpeace, which, with the farmer-scientist network MASIPAG and others, brought the lawsuit.
The Observer’s science editor Robin McKie has published an article accusing Greenpeace of causing “a catastrophe” by its role in the court case. GM Golden Rice is engineered to contain the vitamin A precursor beta-carotene and is targeted at poor people, especially children, suffering from vitamin A deficiency (VAD).
The Observer also chimed in with an editorial headlined, “When modified rice could save thousands of lives, it is wrong to oppose it”, and subtitled, “The green movement’s attempts to block the cultivation of a grain enhanced with vitamin A is misguided”.
However, experts on Golden Rice have roundly debunked the claims, with one pointing out that blaming Greenpeace for blocking the GM crop is “a sleazy sleight of hand to hide the fact that after 30 years of development, Golden Rice is still not ready”. Glenn Davis Stone, Research Professor of Environmental Science at Sweet...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...